new glp-1 drug retatrutide Retatrutide: The Future of Weight Management Next-Gen GLP-1 after Ozempic: Retatrutide
Description
Multiple clinical trials assessing the therapeutic potential of GLP-1 medicines for Parkinsons disease have been completed
Beyond Weight Loss: Additional Benefits of GLP-1s These medications act on appetite-regulating pathways in the brain
Several marketed drugs that are FDA approved are currently included in this group (See Table 1, right)
If you're interested in learning more about them, you've come to the right place
PMID: 34497589
Sica, G
